Detection of Biological Threat Agents by Real-Time PCR: Comparison of Assay Performance on the R.A.P.I.D., the Lightcycler, And the Smart Cycler Platforms (Technical Briefs) Detection of Biological Threat Agents by Real-Time PCR: Comparison of Assay Performance on the R.A.P.I.D., the Lightcycler, And the Smart Cycler Platforms (Technical Briefs)

Detection of Biological Threat Agents by Real-Time PCR: Comparison of Assay Performance on the R.A.P.I.D., the Lightcycler, And the Smart Cycler Platforms (Technical Briefs‪)‬

Clinical Chemistry 2006, Jan, 52, 1

    • 2,99 €
    • 2,99 €

Beschreibung des Verlags

Because disease-causing microorganisms can be used as aerobiological weapons, accurate and timely identification of these agents is necessary (1-4). Important agents include Bacillus anthracis (anthrax), Brucella species (brucellosis), Clostridium botulinum (botulism), Coxiella burnetii (Q fever), Francisella tularensis (tularemia), Staphylococcus aureus, and Yersinia pestis (plague) (5). Real-time PCR can rapidly detect the presence of nucleic acid markers with small reaction volumes and rapid cycling. Assay chemistry is increasingly important in this identification process because the choices and concentrations of enzymes, buffers, salts, primers, and probes affect assay detection limits (6-12). Real-time PCR assays for detecting biological warfare agents have been developed on the R.A.P.I.D.[R] (Idaho Technology, Inc.), LightCycler[R] (Roche), and Smart Cycler[R] (Cepheid) platforms and are compatible with various fluorescence-based methods such as TagMan[R] (13, 14), hybridization probes (15, 16), molecular beacons (17-19), Scorpion primers (20), LUXE primers (21-24), AEGIS primers (25-27), and SimpleProbes[R] (IT Biochem). We investigated whether these assays produce comparable sensitivity and specificity on these rapid cycling instruments.

GENRE
Wissenschaft und Natur
ERSCHIENEN
2006
1. Januar
SPRACHE
EN
Englisch
UMFANG
14
Seiten
VERLAG
American Association for Clinical Chemistry, Inc.
ANBIETERINFO
The Gale Group, Inc., a Delaware corporation and an affiliate of Cengage Learning, Inc.
GRÖSSE
214,9
 kB
Nucleic Acid Detection Technologies--Labels, Strategies, And Formats. Nucleic Acid Detection Technologies--Labels, Strategies, And Formats.
1999
Molecular Analysis and Genome Discovery Molecular Analysis and Genome Discovery
2011
Pcr-Oligonucleotide Ligation Assay from Dried Blood Spots (Technical Briefs) Pcr-Oligonucleotide Ligation Assay from Dried Blood Spots (Technical Briefs)
1999
Molecular Biomethods Handbook Molecular Biomethods Handbook
2008
Fully Automated, Homogeneous Nucleic Acid Detection Technology Based on Dry-Reagent Assay Chemistry and Time-Resolved Fluorometry (Abstracts of Oak Ridge Posters) Fully Automated, Homogeneous Nucleic Acid Detection Technology Based on Dry-Reagent Assay Chemistry and Time-Resolved Fluorometry (Abstracts of Oak Ridge Posters)
2007
Biophysical and Computational Tools in Drug Discovery Biophysical and Computational Tools in Drug Discovery
2021
Highly Sensitive Immunoprecipitation Method for Extracting and Concentrating Low-Abundance Proteins from Human Serum (Technical Briefs) Highly Sensitive Immunoprecipitation Method for Extracting and Concentrating Low-Abundance Proteins from Human Serum (Technical Briefs)
2005
Longitudinal Concentrations of Vitamin [B.Sub.12] and Vitamin [B.Sub.12]-Binding Proteins During Uncomplicated Pregnancy (General Clinical Chemistry) (Clinical Report) Longitudinal Concentrations of Vitamin [B.Sub.12] and Vitamin [B.Sub.12]-Binding Proteins During Uncomplicated Pregnancy (General Clinical Chemistry) (Clinical Report)
2002
Multicenter Characterization and Validation of the Intron-8 Poly(T) Tract (IVS8-T) Status in 25 Coriell Cell Repository Cystic Fibrosis Reference Cell Lines for Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene Mutation Assays (Technical Briefs) Multicenter Characterization and Validation of the Intron-8 Poly(T) Tract (IVS8-T) Status in 25 Coriell Cell Repository Cystic Fibrosis Reference Cell Lines for Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene Mutation Assays (Technical Briefs)
2004
Immunoassay Standardization: Is It Possible, Who Is Responsible, Who Is Capable?(Opinion) (Clinical Report) Immunoassay Standardization: Is It Possible, Who Is Responsible, Who Is Capable?(Opinion) (Clinical Report)
2001
A Conversation with Elizabeth Blackburn (Interview) A Conversation with Elizabeth Blackburn (Interview)
2009
The Evolution of Immunoassay As Seen Through the Journal Clinical Chemistry (Aacc 50th Years Anniversary Retrospective) The Evolution of Immunoassay As Seen Through the Journal Clinical Chemistry (Aacc 50th Years Anniversary Retrospective)
1998